Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial.

Sung-Hee Lim Jina Yun Min-Young Lee Han Jo Kim Kyoung Ha Kim Se Hyung Kim Sang-Cheol Lee Sang Byung Bae Chan-Kyu Kim Namsu Lee Kyu Taek Lee Seong Kyu Park Yun Nah Lee Hyun Jong Choi

Published in: Yonsei medical journal (2021)

The addition of oxaliplatin to a first-line gemcitabine/erlotinib regimen demonstrated higher response rates and significantly improved PFS in patients with locally advanced or metastatic pancreatic cancer.

Keyphrases

locally advanced
squamous cell carcinoma
rectal cancer
neoadjuvant chemotherapy
advanced non small cell lung cancer
epidermal growth factor receptor
phase ii study
radiation therapy
small cell lung cancer
open label
clinical trial
tyrosine kinase
lymph node